2026-10-25 22:06:02 UTC#511946newconfirmednews
BIO stock news
BIO stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-08 12:00:00 UTC#431988newconfirmedpress release
Bio-Techne Opens New GMP Manufacturing Facility in Bristol to Support Scalable Cell Therapy Development
2026-10-02 07:20:06 UTC#403704newconfirmednews
Bio-Techne Corp average analyst price target raised to $73.22, implying 1% upside
2026-09-24 13:53:48 UTC#363012newconfirmedanalysis
Bio-Rad Laboratories outlines multi-year transformation strategy centered on digital PCR and M&A
2026-09-23 13:21:00 UTC#355678updateconfirmednews
Bio-Techne HSR antitrust waiting period expires, clearing regulatory hurdle for pending acquisition
2026-09-23 13:21:00 UTC#355676newconfirmednews
Bio-Techne Corporation reaffirms expected transaction closing date for late 2026 or early 2027
2026-09-23 13:20:00 UTC#355688duplicateconfirmedpress release
Bio-Techne shareholders approve definitive acquisition agreement by Merck KGaA
2026-09-23 13:20:00 UTC#355683duplicateconfirmedpress release
Bio-Techne shareholders approve definitive merger agreement with Merck KGaA
2026-09-23 13:20:00 UTC#355681duplicateconfirmednews
Bio-Techne shareholders approve acquisition by Merck KGaA
2026-09-23 13:20:00 UTC#355680updateconfirmednews
Bio-Techne shareholders approve acquisition by Merck KGaA; deal closing expected late 2026 or early 2027
2026-09-22 13:00:00 UTC#348909newconfirmedpress release
Bio-Techne opens new customer experience center in Düsseldorf to support EMEA life sciences research
2026-09-14 23:53:21 UTC#310726newconfirmednews
BIO Reports FY26 Revenue of $23.9M, Up 30%, With 62.1% Gross Margin and China Market Entry
2026-09-14 21:13:33 UTC#310203newconfirmednews
Bio-Techne supplements proxy for Merck KGaA merger vote after shareholder litigation; meeting set for Sept. 23
tradingviewimportance 0.50trust 0.80Bio-Techne Corporation -0.10Merck KGaA +0.10The Goldman Sachs Group, Inc. 0
2026-09-04 14:13:04 UTC#268820newconfirmednews
Kate Beebe DeVarney resigns from Bio board of directors effective August 31, 2026
2026-09-04 09:48:00 UTC#267496newconfirmednews
Global Multiplex Assays Market Forecast to Reach $12.4B by 2030 at 12.8% CAGR, ResearchAndMarkets Reports
yahooimportance 0.30trust 0.60Thermo Fisher Scientific Inc. +0.10Bio-Rad Laboratories, Inc. +0.10QIAGEN N.V. +0.10+2 entities
2026-09-01 10:30:00 UTC#248171newconfirmedpress release
Bio-Techne receives SBTi validation for emissions targets, reports 49% reduction in Scope 1 and 2 emissions
pr_newswireimportance 0.30trust 0.90Bio-Techne Corporation +0.30Science Based Targets initiative +0.30
2026-08-27 01:28:58 UTC#226355newconfirmednews
Biome Australia to launch Activated Probiotics range in China via cross-border e-commerce in FY27
2026-08-18 02:18:00 UTC#187470newconfirmednews
Halper Sadeh LLC Investigates Payoneer $7.40/share Sale to Nuvei and Bio-Techne $73.00/share Sale to Merck KGaA
pr_newswireimportance 0.30trust 0.40Payoneer Global Inc. -0.20Nuvei Corporation +0.20Bio-Techne Corporation -0.20+2 entities
2026-08-17 10:29:06 UTC#183936newconfirmednews
German Federal Cartel Office approves Merck KGaA's 10 billion euro acquisition of Bio-Techne
2026-08-13 21:45:00 UTC#174829newconfirmednews